Why all randomised controlled trials produce biased results

被引:87
作者
Krauss, Alexander [1 ]
机构
[1] UCL, London Sch Econ, London, England
关键词
Randomised controlled trial; RCT; reproducibility crisis; replication crisis; bias; statistical bias; evidence-based medicine; evidence-based practice; reproducibility of results; clinical medicine; research design; PLUS; INTERVENTION; EFFICACY; QUALITY; THERAPY;
D O I
10.1080/07853890.2018.1453233
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Randomised controlled trials (RCTs) are commonly viewed as the best research method to inform public health and social policy. Usually they are thought of as providing the most rigorous evidence of a treatments effectiveness without strong assumptions, biases and limitations. Objective: This is the first study to examine that hypothesis by assessing the 10 most cited RCT studies worldwide. Data sources: These 10 RCT studies with the highest number of citations in any journal (up to June 2016) were identified by searching Scopus (the largest database of peer-reviewed journals). Results: This study shows that these world-leading RCTs that have influenced policy produce biased results by illustrating that participants' background traits that affect outcomes are often poorly distributed between trial groups, that the trials often neglect alternative factors contributing to their main reported outcome and, among many other issues, that the trials are often only partially blinded or unblinded. The study here also identifies a number of novel and important assumptions, biases and limitations not yet thoroughly discussed in existing studies that arise when designing, implementing and analysing trials. Conclusions: Researchers and policymakers need to become better aware of the broader set of assumptions, biases and limitations in trials. Journals need to also begin requiring researchers to outline them in their studies. We need to furthermore better use RCTs together with other research methods.
引用
收藏
页码:312 / 322
页数:11
相关论文
共 31 条
  • [1] Reinventing clinical trials
    Allison, Malorye
    [J]. NATURE BIOTECHNOLOGY, 2012, 30 (01) : 41 - 49
  • [2] A PROPOSAL FOR STRUCTURED REPORTING OF RANDOMIZED CONTROLLED TRIALS
    ANDREW, E
    ANIS, A
    CHALMERS, T
    CHO, M
    CLARKE, M
    FELSON, D
    GOTZSCHE, P
    GREENE, R
    JADAD, A
    JONAS, W
    KLASSEN, T
    KNIPSCHILD, P
    LAUPACIS, A
    MEINERT, CL
    MOHER, D
    NICHOL, G
    OXMAN, A
    PENMAN, MF
    POCOCK, S
    REISCH, J
    SACKETT, D
    SCHULZ, K
    SNIDER, J
    TUGWELL, P
    TYSON, J
    VARIN, F
    WALOP, W
    WALSH, S
    WELLS, G
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (24): : 1926 - 1931
  • [3] [Anonymous], 244 LOND SCH EC
  • [4] Banerjee AbhijitV., 2007, MAKING AID WORK
  • [5] Scope and impact of financial conflicts of interest in biomedical research - A systematic review
    Bekelman, JE
    Li, Y
    Gross, CP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (04): : 454 - 465
  • [6] Black N, 1996, BRIT MED J, V312, P1215
  • [7] Epidemiology and reporting of randomised trials published in PubMed journals
    Chan, AW
    Altman, DG
    [J]. LANCET, 2005, 365 (9465) : 1159 - 1162
  • [8] Trial unpredictability yields predictable therapy gains
    Djulbegovic, Benjamin
    Kumar, Ambuj
    Glasziou, Paul
    Miladinovic, Branko
    Chalmers, Iain
    [J]. NATURE, 2013, 500 (7463) : 395 - 396
  • [9] Duflo Esther., 2007, Handbook of Development Economics
  • [10] Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
    Dwan, Kerry
    Altman, Douglas G.
    Arnaiz, Juan A.
    Bloom, Jill
    Chan, An-Wen
    Cronin, Eugenia
    Decullier, Evelyne
    Easterbrook, Philippa J.
    Von Elm, Erik
    Gamble, Carrol
    Ghersi, Davina
    Ioannidis, John P. A.
    Simes, John
    Williamson, Paula R.
    [J]. PLOS ONE, 2008, 3 (08):